Skip to main content
Xvivo Perfusion logo

Xvivo Perfusion — Investor Relations & Filings

Ticker · XVIVO ISIN · SE0004840718 LEI · 549300G2464FYLS14B41 ST Manufacturing
Open in API
Filings indexed 286 across all filing types
Latest filing 2020-03-31 AGM Information
Country SE Sweden
Listing ST XVIVO

About Xvivo Perfusion

https://www.xvivogroup.com/

Xvivo Perfusion is a medical technology company specializing in ex-vivo organ preservation for transplantation. The company develops machine perfusion technologies, solutions, and services designed to extend the life of major organs, including lungs, livers, and kidneys. Its core technology, organ perfusion, is an alternative to static cold storage that continuously supplies an organ with an oxygenated solution while it is outside the body. This process helps support cellular function, prevent tissue damage, and allows clinicians to assess organ viability prior to transplant. The company's objective is to increase organ utilization, extend preservation times, and improve patient outcomes. Key products include the XPS™ for lung perfusion, Liver Assist™, Kidney Assist Transport™, and the PERFADEX® Plus solution for lung preservation.

Recent filings

Filing Released Lang Actions
Report from Annual general meeting of XVIVO Perfusion AB (publ)
AGM Information Classification · 99% confidence The document is explicitly titled "REPORT FROM ANNUAL GENERAL MEETING OF XVIVO PERFUSION AB (PUBL)" and details resolutions adopted at the AGM, including board elections, remuneration, and shareholder authorizations (share issuance, warrants, share buybacks). This directly corresponds to the definition of AGM Information. Although it is presented as a press release, the content is the outcome/report of the meeting itself, not just an announcement of the meeting date or a proxy statement. Therefore, the most specific classification is AGM-R.
2020-03-31 English
XPS™ såld till pediatrisk transplantationsklinik i Italien
Regulatory Filings Classification · 95% confidence The document is a press release from XVIVO Perfusion announcing the sale of an XPS system to a pediatric transplant clinic in Italy. It is a corporate announcement regarding business operations and product sales, not a financial report, proxy, or regulatory filing of a specific type. As it does not fit into the specialized categories like M&A, dividends, or director dealings, it falls under the general regulatory announcement category.
2020-03-31 Swedish
XPS™ sold to pediatric transplantation clinic in Italy
Regulatory Filings Classification · 98% confidence The document is a press release from XVIVO Perfusion announcing the sale of an XPS machine to a pediatric clinic in Italy. It is a short, news-oriented announcement regarding company business activities rather than a formal financial report, proxy statement, or regulatory filing. Since it does not fit into specific categories like M&A, dividends, or director dealings, and serves as a general corporate announcement, it falls under the Regulatory Filings (RNS) category.
2020-03-31 English
Valberedningen föreslår oförändrade styrelsearvoden – justerad version
Remuneration Information Classification · 95% confidence The document is a press release dated March 25, 2020, titled "Valberedningen föreslår oförändrade styrelsearvoden – justerad version" (The Nomination Committee proposes unchanged board fees – adjusted version). It explicitly discusses changes to proposals regarding board remuneration to be voted on at the upcoming Annual General Meeting (AGM). While it relates to the AGM agenda, the core subject matter is the compensation structure for the board of directors. The filing category 'Remuneration Information' (DEF 14A) is defined as 'Report detailing compensation for top executives and directors.' Although this is a press release announcing a change to a proposal, the subject matter is remuneration, making DEF 14A the most specific fit among the options, as it directly addresses director compensation proposals, even if it's an announcement rather than the final proxy statement itself. Given the options, DEF 14A is superior to AGM-R (which is for presentations/materials) or RNS (which is a fallback). The document length is short (2278 chars), but it is a substantive announcement about remuneration, not just a notice that a report is available.
2020-03-25 Swedish
The Nomination Committee proposes unchanged Board remuneration -adjusted version
Remuneration Information Classification · 95% confidence The document is a press release dated March 25, 2020, titled "The Nomination Committee proposes unchanged Board remuneration adjusted." It explicitly discusses a proposal regarding Board remuneration to be voted on at the Annual General Meeting (AGM) on March 31, 2020. While it relates to the AGM, the core subject is the compensation structure for the board members, which falls under Remuneration Information (DEF 14A). Although AGM-R covers AGM materials, DEF 14A is specifically for compensation details. Since this is a proposal/announcement about remuneration, DEF 14A is the most precise fit, even though it's presented as a press release.
2020-03-25 English
Valberedningen föreslår oförändrade styrelsearvoden
AGM Information Classification · 95% confidence The document is a press release from XVIVO Perfusion regarding a change to a proposal for the upcoming Annual General Meeting (AGM). Specifically, it announces that the nomination committee is withdrawing a proposal to increase board fees due to the COVID-19 pandemic and instead proposes keeping them unchanged. Since this relates to the agenda and governance proposals for an upcoming AGM, it falls under the category of AGM Information.
2020-03-25 Swedish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.